https://simplecast.com Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse. Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals. Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice. 2023 Proactive Investors en Wed, 4 Jun 2025 04:59:47 +0000 Wed, 4 Jun 2025 04:59:58 +0000 https://after-market.simplecast.com https://image.simplecastcdn.com/images/9d287439-8946-4dd1-b470-7a659ae84b0f/110910b9-df55-4c8c-8e23-bfdee5147642/3000x3000/after-market-cover-01.jpg?aid=rss_feed https://after-market.simplecast.com episodic Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse. Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals. Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice. Proactive Australia false https://feeds.simplecast.com/AwMWPN4S #invest, proactive investors australia, #investing, investment, #stockmarket, #stockmarketnews, #stocks #stock #stockmarketnews, after market, asx, business news, investors, proactive, proactive investors, stock, stock market news, stocks, tech news Proactive Investors jamie@proactiveinvestors.com 5ba14acf-2cdb-4611-8ff2-23b4e533ecd8 Wed, 4 Jun 2025 04:59:47 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/asx-companies-turn-to-otc-markets-for-dual-listing-iZbQToE1 ASX companies turn to OTC Markets for dual listing Proactive Investors 00:11:38 In this episode, OTC Markets Group executive vice president Jason Paltrowitz joins Proactive to discuss how international companies—especially those listed on the Australian Securities Exchange (ASX)—can efficiently expand their reach to United States investors through secondary trading on OTC Markets. Paltrowitz explains the challenges U.S. investors face when trying to access equities listed on overseas exchanges such as the ASX, London Stock Exchange, or Euronext Paris. He outlines how OTC Markets bridges this gap by allowing these companies to make their shares available in U.S. dollars during U.S. trading hours, through regulated trading platforms. The episode also explores OTC Markets’ three-tiered structure, with a focus on OTCQX—the “best market”—and OTCQB, the “venture market,” tailored for growth-stage companies. Over 80 ASX-listed companies are already leveraging these platforms. Paltrowitz introduces the “List Local, Trade Global” strategy, enabling firms to maintain their primary listings at home while gaining exposure to U.S. liquidity—without the added burden of full U.S. regulatory compliance such as SEC filing or Sarbanes-Oxley. The conversation concludes with a look at rising U.S. investor interest in international equities—Asian and European trading volumes have surged—and previews upcoming innovations like overnight trading and the OTCID platform aimed at enhancing market access and transparency. In this episode, OTC Markets Group executive vice president Jason Paltrowitz joins Proactive to discuss how international companies—especially those listed on the Australian Securities Exchange (ASX)—can efficiently expand their reach to United States investors through secondary trading on OTC Markets. Paltrowitz explains the challenges U.S. investors face when trying to access equities listed on overseas exchanges such as the ASX, London Stock Exchange, or Euronext Paris. He outlines how OTC Markets bridges this gap by allowing these companies to make their shares available in U.S. dollars during U.S. trading hours, through regulated trading platforms. The episode also explores OTC Markets’ three-tiered structure, with a focus on OTCQX—the “best market”—and OTCQB, the “venture market,” tailored for growth-stage companies. Over 80 ASX-listed companies are already leveraging these platforms. Paltrowitz introduces the “List Local, Trade Global” strategy, enabling firms to maintain their primary listings at home while gaining exposure to U.S. liquidity—without the added burden of full U.S. regulatory compliance such as SEC filing or Sarbanes-Oxley. The conversation concludes with a look at rising U.S. investor interest in international equities—Asian and European trading volumes have surged—and previews upcoming innovations like overnight trading and the OTCID platform aimed at enhancing market access and transparency. false full 20 795a9605-d70e-4cad-a029-2510ad9b1110 Fri, 28 Mar 2025 02:58:02 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/safer-chemotherapy-race-oncologys-new-drug-heads-to-trials-NI3nuR4E Safer chemotherapy? Race Oncology’s new drug heads to trials Proactive Investors 00:25:41 Race Oncology Ltd is advancing the development of a reformulated chemotherapy drug aimed at reducing severe side effects, particularly cardiac-related risks, while preserving or improving efficacy. In this episode of After Market with Jonathan Jackson, CEO and managing director Daniel Tillett highlighted the drug’s potential to work alongside anthracyclines, a common class of chemotherapy agents, to enhance patient safety and treatment outcomes. The company is preparing for clinical trials to evaluate the drug’s performance in human subjects. Race Oncology Ltd is advancing the development of a reformulated chemotherapy drug aimed at reducing severe side effects, particularly cardiac-related risks, while preserving or improving efficacy. In this episode of After Market with Jonathan Jackson, CEO and managing director Daniel Tillett highlighted the drug’s potential to work alongside anthracyclines, a common class of chemotherapy agents, to enhance patient safety and treatment outcomes. The company is preparing for clinical trials to evaluate the drug’s performance in human subjects. false full 19 94b512b9-ab59-4117-9872-d42ca839f8b0 Tue, 28 May 2024 00:25:52 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/the-state-of-drug-development-in-australia-a-case-study-hd5LHOcT The state of drug development in Australia: a case study Proactive Investors 00:28:47 Amplia Therapeutics Ltd CEO and managing director Dr Chris Burns has had a long career in drug development, including discovering only the second Australian drug to receive US FDA approval. He has plenty of advice to share for Australian-based researchers and domestically developed biotech assets. Proactive's Susanna Nelson chats to him about the current state of clinical research and commercial drug development in Australia. Amplia Therapeutics Ltd CEO and managing director Dr Chris Burns has had a long career in drug development, including discovering only the second Australian drug to receive US FDA approval. He has plenty of advice to share for Australian-based researchers and domestically developed biotech assets. Proactive's Susanna Nelson chats to him about the current state of clinical research and commercial drug development in Australia. false full 18 2d7fe81b-7436-41bc-85dc-3d9c79b1e957 Thu, 14 Mar 2024 04:58:40 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/australian-vanadium-reinforces-potential-for-long-lasting-high-grade-vanadium-and-battery-metal-project-VO37n3Ld Australian Vanadium reinforces potential for long-lasting, high-grade vanadium and battery metal project Proactive Investors 00:18:30 Australian Vanadium Ltd (ASX:AVL) CEO Graham Arvidson sits down with Proactive’s Jonathan Jackson to discuss progress in the company's metallurgical testing following a recent merger with Technology Metals Australia Ltd (TMT). AVL plans to capitalise on the battery metal boom with its vanadium and high-grade iron project, leveraging its subsidiary VSUN to build out the Vanadium Flow Battery market and other future tech applications. Australian Vanadium Ltd (ASX:AVL) CEO Graham Arvidson sits down with Proactive’s Jonathan Jackson to discuss progress in the company's metallurgical testing following a recent merger with Technology Metals Australia Ltd (TMT). AVL plans to capitalise on the battery metal boom with its vanadium and high-grade iron project, leveraging its subsidiary VSUN to build out the Vanadium Flow Battery market and other future tech applications. false full 17 af8f629b-6a28-47ec-ac76-fc1d967b131c Tue, 13 Feb 2024 01:17:14 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/carbon-capture-and-storage-an-essential-part-of-the-circular-economy-h6TtveQJ Carbon capture and storage: An essential part of the circular economy Proactive Investors 00:15:44 How can resource companies mitigate their carbon emissions in innovative ways? Proactive’s Phoebe Shields talks to CSIRO’s Dr Dia Milani, who leads the organisation’s CO2 utilisation team within the Sustainable Carbon Technologies group, about the urgency of including carbon capture and storage methods in the mix of tools to combat climate change – and the opportunities that abound for companies to apply the technology in Australia. How can resource companies mitigate their carbon emissions in innovative ways? Proactive’s Phoebe Shields talks to CSIRO’s Dr Dia Milani, who leads the organisation’s CO2 utilisation team within the Sustainable Carbon Technologies group, about the urgency of including carbon capture and storage methods in the mix of tools to combat climate change – and the opportunities that abound for companies to apply the technology in Australia. false full 16 b75d4d18-e179-45a1-be93-f0ff037c5ef4 Fri, 5 Jan 2024 03:21:44 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/after-market-episode-15-artemis-resources-is-chasing-gold-copper-and-lithium-in-the-pilbara-IRF1veWU Artemis Resources is chasing gold, copper and lithium in the Pilbara Proactive Investors 00:18:33 Artemis Resources Ltd executive director George Ventouras talks to Proactive’s Susanna Nelson about the company’s projects, mostly in the West Pilbara, where it is exploring for gold, copper and lithium. George also weighs in on ‘the white gold boom’, the importance of a diverse and sustainable mining industry to the Australian economy and the future of mining in this country. Artemis Resources Ltd executive director George Ventouras talks to Proactive’s Susanna Nelson about the company’s projects, mostly in the West Pilbara, where it is exploring for gold, copper and lithium. George also weighs in on ‘the white gold boom’, the importance of a diverse and sustainable mining industry to the Australian economy and the future of mining in this country. false full 15 b3fe0798-9b3a-4770-a162-269be75543a1 Mon, 4 Dec 2023 02:24:01 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/after-market-episode-14-how-does-australia-get-the-best-out-of-its-relationship-with-china-jOMpTpwi How does Australia get the best out of its relationship with China? Proactive Investors 00:21:49 China is our biggest trading partner. In this introduction to the topic, mining publisher and China entrepreneur Yolanda Torrisi tells Proactive about the Australian industries that are most exposed to the trading giant, whether diplomatic relations are starting to defrost, and how we can leverage the relationship to our best advantage at a time of uncertainty for global markets and supply chains. China is our biggest trading partner. In this introduction to the topic, mining publisher and China entrepreneur Yolanda Torrisi tells Proactive about the Australian industries that are most exposed to the trading giant, whether diplomatic relations are starting to defrost, and how we can leverage the relationship to our best advantage at a time of uncertainty for global markets and supply chains. false full 14 a8fa88b8-0257-4bb1-8808-43db5be3682d Fri, 17 Nov 2023 04:19:03 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/provaris-an-early-mover-on-green-hydrogen-supply-chain-in-europe-aaVFRm8m Provaris an early mover on green hydrogen supply chain in Europe Proactive Investors 00:06:56 Energy security is critical in these days of geopolitical unrest. Provaris Energy Ltd has seen the writing on the wall and has forged ahead with its business model of simple and efficient hydrogen production and transportation. MD and CEO Martin Carolan tells Proactive's Susanna Nelson the company is currently in the design phase of a prototype tank for compressed hydrogen, with construction and testing planned in Norway for the first quarter of 2024. A range of government and independent stakeholders are interested, too. Energy security is critical in these days of geopolitical unrest. Provaris Energy Ltd has seen the writing on the wall and has forged ahead with its business model of simple and efficient hydrogen production and transportation. MD and CEO Martin Carolan tells Proactive's Susanna Nelson the company is currently in the design phase of a prototype tank for compressed hydrogen, with construction and testing planned in Norway for the first quarter of 2024. A range of government and independent stakeholders are interested, too. false full 13 f7b9e4c1-1d27-47e5-b82d-ac843f002851 Tue, 7 Nov 2023 02:29:09 +0000 jamie@proactiveinvestors.com (Phoebe Shields) https://after-market.simplecast.com/episodes/moving-clinical-trials-out-of-the-hospital-and-into-general-practice-IUJ_95aW Moving clinical trials out of the hospital and into general practice Phoebe Shields 00:23:14 Clinical trials are, by necessity, subject to rigorous guidelines to protect human health. Proactive’s Phoebe Shields talks to Evrima founder and CEO Charlotte Bradshaw about her company’s data-driven patient matching system, which verifies and matches participants’ electronic medical records to trial protocols. This breaks down barriers to trial recruitment such as awareness, hospital-centricity, distribution of patients, commitment to participation and suitability to take part. Clinical trials are, by necessity, subject to rigorous guidelines to protect human health. Proactive’s Phoebe Shields talks to Evrima founder and CEO Charlotte Bradshaw about her company’s data-driven patient matching system, which verifies and matches participants’ electronic medical records to trial protocols. This breaks down barriers to trial recruitment such as awareness, hospital-centricity, distribution of patients, commitment to participation and suitability to take part. false full 12 77b6a36d-cd4e-4776-89f2-242f240c7b92 Fri, 3 Nov 2023 05:06:07 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/imugene-forges-ahead-with-metastatic-advanced-solid-tumour-mast-trial-SVaNrOx7 Imugene forges ahead with VAXINIA trial targeting solid tumours Proactive Investors 00:08:42 Clinical-stage immuno-oncology biotech Imugene has been making significant strides in the development of therapies targeting a range of cancers. In this episode of After Market, MD and CEO Leslie Chong tells Susanna Nelson about the company's Phase 1 metastatic advanced solid tumours, or MAST, trial, which has been designed to evaluate the safety and efficacy of the cancer-killing virus CF33-hNIS (VAXINIA). Clinical-stage immuno-oncology biotech Imugene has been making significant strides in the development of therapies targeting a range of cancers. In this episode of After Market, MD and CEO Leslie Chong tells Susanna Nelson about the company's Phase 1 metastatic advanced solid tumours, or MAST, trial, which has been designed to evaluate the safety and efficacy of the cancer-killing virus CF33-hNIS (VAXINIA). false full 11 b4d6c23c-4acb-4489-b7bb-3f1630426649 Mon, 2 Oct 2023 02:51:52 +0000 jamie@proactiveinvestors.com (Brendan Paul, Susanna Nelson) https://after-market.simplecast.com/episodes/building-a-diverse-portfolio-during-economic-uncertainty-5QeoiCOf Building a diverse portfolio during economic uncertainty Brendan Paul, Susanna Nelson 00:20:50 The last few years have seen investors buffeted by the winds of pandemic and war, bringing with them supply chain issues, overcooked inflation and much-dreaded rate hikes. Atrium senior portfolio manager Brendan Paul talks to Proactive about why it’s an interesting time to be an investor, what risk really means and the importance of building a truly diverse asset portfolio in uncertain times. The last few years have seen investors buffeted by the winds of pandemic and war, bringing with them supply chain issues, overcooked inflation and much-dreaded rate hikes. Atrium senior portfolio manager Brendan Paul talks to Proactive about why it’s an interesting time to be an investor, what risk really means and the importance of building a truly diverse asset portfolio in uncertain times. diverse asset portfolio, managing stocks, growth stocks, risk hedging, stock portfolio, inflation, managing risk, strategic investing, risk false full 10 02159bd6-e0b9-4be7-91c9-cdaef0d42a72 Tue, 29 Aug 2023 04:06:33 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/antimicrobial-resistance-and-the-coming-plague-7Y0ZHqlz Antimicrobial resistance and the coming plague Proactive Investors 00:23:43 Antimicrobial resistance means the age of antibiotics – when humanity has had the luxury of fixing or preventing all manner of disease with a simple biological agent in a capsule – is coming to an end. Recce Pharmaceuticals CEO James Graham talks to Proactive’s Susanna Nelson about how we stay one step ahead in the fight against deadly pathogens and avoid the next superbug. Antimicrobial resistance means the age of antibiotics – when humanity has had the luxury of fixing or preventing all manner of disease with a simple biological agent in a capsule – is coming to an end. Recce Pharmaceuticals CEO James Graham talks to Proactive’s Susanna Nelson about how we stay one step ahead in the fight against deadly pathogens and avoid the next superbug. antibitoic resistant bacteria, synthetic anti-infectives, biotech, plague, viral pathogens, biopharmaceuticals, anti-infectives, antibiotic resistance, superbug false full 9 108dca85-7ee1-4929-a3f1-3ae9190c3ba6 Mon, 31 Jul 2023 02:00:00 +0000 jamie@proactiveinvestors.com (Chris Vernon, Phoebe Shields) https://after-market.simplecast.com/episodes/australias-green-critical-mineral-opportunity-_joR68Wy Australia's green critical mineral opportunity Chris Vernon, Phoebe Shields 00:30:33 The critical mineral boom is taking off. CSIRO senior principal research scientist and Green Mineral Technologies initiative leader Chris Vernon walks Proactive’s Phoebe Shields through the oncoming critical mineral supply dearth, the need for down-stream trade relationships and the potential effect of a circular economy on the mining industry. The critical mineral boom is taking off. CSIRO senior principal research scientist and Green Mineral Technologies initiative leader Chris Vernon walks Proactive’s Phoebe Shields through the oncoming critical mineral supply dearth, the need for down-stream trade relationships and the potential effect of a circular economy on the mining industry. cobalt mining, sustainability, green mining, battery metal mining, circular economy, electric vehicle batteries, platinum group elements mining, platinum group elements, net zero, critical minerals, green critical minerals, energy transformation, critical mineral mining, electric vehicle manufacturing, rare earth elements mining, critical mineral supply shortage, cobalt, energy transition, platinum group metals, sustainable mining, rare earth elements, battery manufacturing, lithium, nickel mining, battery metals, lithium mining, nickel false full 8 fc3f3c18-cc12-49f8-80d1-39a3c071efaf Tue, 27 Jun 2023 01:07:43 +0000 jamie@proactiveinvestors.com (Michael Winlo, Susanna Nelson) https://after-market.simplecast.com/episodes/cannabis-and-psychedelic-regulation-in-australia-16mUxx97 Cannabis and psychedelic regulation in Australia Michael Winlo, Susanna Nelson 00:25:32 What are the rules governing cannabis and psychedelics in Australia? How have attitudes to these substances changed over time, and what does the Australian biotech industry need governments to do to unlock the myriad therapeutic benefits they promise? Emyria's Dr Michael Winlo answers these questions and more in this interview with Proactive's Susanna Nelson. What are the rules governing cannabis and psychedelics in Australia? How have attitudes to these substances changed over time, and what does the Australian biotech industry need governments to do to unlock the myriad therapeutic benefits they promise? Emyria's Dr Michael Winlo answers these questions and more in this interview with Proactive's Susanna Nelson. therapy, mdma, mental health, depression, psychedelic regulation, psychedelics, biotech, psilocybin, anxiety, cannabis, psychedelic-assisted therapy, cannabis regulation, ptsd false full 7 8f7a17a3-6bd1-4929-8f6b-a7721e2908cd Wed, 31 May 2023 03:26:17 +0000 jamie@proactiveinvestors.com (Warwick Talbot, Phoebe Shields) https://after-market.simplecast.com/episodes/how-ai-is-changing-the-way-we-do-business-I9OQ9HHk How AI is changing the way we do business Warwick Talbot, Phoebe Shields 00:26:30 With AI all over news, it’s hard to sort out the opportunity from the threat. Avanade’s Warwick Talbot tells Proactive’s Phoebe Shields about the business potential presented by digitisation, machine learning’s use in data curation and real time insights, and the emergence of the industrial metaverse and digital twinning. With AI all over news, it’s hard to sort out the opportunity from the threat. Avanade’s Warwick Talbot tells Proactive’s Phoebe Shields about the business potential presented by digitisation, machine learning’s use in data curation and real time insights, and the emergence of the industrial metaverse and digital twinning. productivity, digital transformation, artificial intelligence, sustainability, ml, industrial metaverse, machine learning, llm, research, chatgpt, digital twinning, data, digital twin, ai, large language models, generative ai, digitisation false full 6 61772614-3b82-406e-9e84-5c2c271f98ad Wed, 31 May 2023 03:25:16 +0000 jamie@proactiveinvestors.com (Ian Hamm, Sue Nelson) https://after-market.simplecast.com/episodes/the-interplay-between-indigenous-rights-and-mining-HELKg700 The interplay between indigenous rights and mining Ian Hamm, Sue Nelson 00:34:41 Long-time indigenous policy maker and advocate Ian Hamm chats to Proactive’s Susanna Nelson about the complex interplay between mining and Aboriginal rights over time. Ian argues for a seat at the board table for Aboriginal and Torres Strait Islander Peoples and expresses his hope that the looming referendum on the Voice to Parliament will usher in a period of genuine change. Long-time indigenous policy maker and advocate Ian Hamm chats to Proactive’s Susanna Nelson about the complex interplay between mining and Aboriginal rights over time. Ian argues for a seat at the board table for Aboriginal and Torres Strait Islander Peoples and expresses his hope that the looming referendum on the Voice to Parliament will usher in a period of genuine change. indigenous rights, first nations australians, the voice, indigenous leadership, indigenous issues, indigenous voice, native title, mining and indigenous rights, the voice to parliament false full 5 9bf80652-a4f0-4c86-87eb-38373ef1551a Wed, 31 May 2023 03:23:18 +0000 jamie@proactiveinvestors.com (Chris Jones, Phoebe Shields) https://after-market.simplecast.com/episodes/the-electric-vehicle-landscape-in-australia-QZN58h9r The electric vehicle landscape in Australia Chris Jones, Phoebe Shields 00:33:39 Australian Electric Vehicle Association president Dr Chris Jones discusses the past, present and future of electric vehicles with Proactive’s Phoebe Shields, with insights from his own career in academia and as a change maker. What will be needed to bring about a change in attitudes toward the transportation of the future in Australia, and how do we achieve it? Australian Electric Vehicle Association president Dr Chris Jones discusses the past, present and future of electric vehicles with Proactive’s Phoebe Shields, with insights from his own career in academia and as a change maker. What will be needed to bring about a change in attitudes toward the transportation of the future in Australia, and how do we achieve it? aeva, electrc vehicle infrastructure, electric vehicles, net zero, decarbonisation, future of eletric vehicles, electric vehicle policy, energy transition, evs, electric vehicle rebates, australian electric vehicle association, electrification false full 4 bdc535d1-75c9-4e37-b217-87d757b53c83 Wed, 31 May 2023 03:20:34 +0000 jamie@proactiveinvestors.com (Julian Ford, Phoebe Shields) https://after-market.simplecast.com/episodes/calculated-risk-in-the-battery-metals-market-lzgJz8PQ Calculated risk in the battery metals market Julian Ford, Phoebe Shields 00:43:38 Riversgold Ltd CEO Julian Ford talks to Proactive’s Phoebe Shields about the importance of the current battery minerals rush, and describes his journey from Apartheid South Africa to Australia and how it shaped his attitude to work, life and mining. A troubleshooter by nature, Ford looks for solutions, and there is none more pressing than the need to ramp up critical minerals production at a time of global decarbonisation. Riversgold Ltd CEO Julian Ford talks to Proactive’s Phoebe Shields about the importance of the current battery minerals rush, and describes his journey from Apartheid South Africa to Australia and how it shaped his attitude to work, life and mining. A troubleshooter by nature, Ford looks for solutions, and there is none more pressing than the need to ramp up critical minerals production at a time of global decarbonisation. small cap mining, sustainability, integrity, gfc, decarbonisation, junior mining, restructuring companies, can-do attitude, mining, lithium, battery metals false full 3 2dda8a8d-356d-42c4-82f1-362329781ee9 Wed, 31 May 2023 03:19:36 +0000 jamie@proactiveinvestors.com (Phoebe Shields, Alex Biggs) https://after-market.simplecast.com/episodes/critical-minerals-mining-and-the-social-contract-9ai8QXcu Critical minerals mining and the social contract Phoebe Shields, Alex Biggs 00:35:17 Lightning Minerals CEO Alex Biggs tells Proactive’s Phoebe Shields about his eventful early life, personal hardship and eventual foray into critical minerals mining. Alex explains how his background has informed his personal philosophy and why resilience, integrity and a commitment to the social contract is key to his understanding of why he does what he does. Lightning Minerals CEO Alex Biggs tells Proactive’s Phoebe Shields about his eventful early life, personal hardship and eventual foray into critical minerals mining. Alex explains how his background has informed his personal philosophy and why resilience, integrity and a commitment to the social contract is key to his understanding of why he does what he does. esg, small cap mining, social contract, white gold, sustainability, net zero, critical minerals, responsible mining, decarbonisation, junior mining, mining, energy transition, sustainable mining, lithium, battery metals false full 2 45e78ebd-152d-4d83-8a1c-0dbd341ca398 Thu, 25 May 2023 03:42:31 +0000 jamie@proactiveinvestors.com (Proactive Investors) https://after-market.simplecast.com/episodes/after-market-trailer-q709P8f9 After Market - Trailer Proactive Investors 00:00:44 Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse. Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals. Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice. Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse. Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals. Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice. false full 1